1. Kitchin et al. “A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85” Clinical Infectious Disease May 24. Epub Ahead of print 2019
DISCLAIMER:The comments made during these videos are offered only for general informational and educational purposes. Dr. Feuerstadt's comments are not offered as and do not constitute medical advice or legal opinions and no statement made during these videos is intended to replace your independent and professional judgment.